Roche Holding AG Stock
Price
Target price
€385.80
€385.80
-1.930%
-7.6
-1.930%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Financial data and news for Roche
sharewise wants to provide you with the best news and tools for Roche, so we directly link to the best financial data sources.
Financials
News
Seer Q2 Earnings Call Highlights
Key Points
- Interested in Seer, Inc.? Here are five stocks we like better.
- Seer’s second-quarter revenue fell year over year to $3.1 million from $4.1 million, pressured by academic and
Lineage Cell Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in Lineage Cell Therapeutics, Inc.? Here are five stocks we like better.
- Pipeline progress: Lineage advanced preclinical programs in corneal disease, Type 1 diabetes and
Tandem Diabetes Care Q2 Earnings Call Highlights
Key Points
- Interested in Tandem Diabetes Care, Inc.? Here are five stocks we like better.
- Record second-quarter performance: Worldwide sales rose 6% year over year to $255 million, while pump
Information Services Group Q2 Earnings Call Highlights
Key Points
- Interested in Information Services Group, Inc.? Here are five stocks we like better.
- Strong second-quarter performance: Revenue rose 6.4% to $65.5 million and adjusted EBITDA
OraSure Technologies Q2 Earnings Call Highlights
Key Points
- Interested in OraSure Technologies, Inc.? Here are five stocks we like better.
- Q2 revenue rose 9.7% sequentially to $30.6 million, exceeding guidance, as diagnostic-products revenue
Recursion Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Recursion Pharmaceuticals, Inc.? Here are five stocks we like better.
- Recursion advanced its pipeline, moving its first neuroscience target from the Roche/Genentech
Madrigal Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Madrigal Pharmaceuticals, Inc.? Here are five stocks we like better.
- Rezdiffra sales rose 71% year over year to $364.3 million in Q2 2026, with nearly $1.3 billion in
Alnylam Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Alnylam Pharmaceuticals, Inc.? Here are five stocks we like better.
- Second-quarter revenue surged 74% to approximately $1.2 billion, driven by AMVUTTRA, which
The Hanover Insurance Group Q2 Earnings Call Highlights
The Hanover Insurance Group (NYSE:THG) reported record second-quarter operating performance, citing improved underwriting margins, accelerating premium growth and higher investment income across